Skip to main content
Premium Trial:

Request an Annual Quote

MGI Receives China FDA Registration for Sequencers

NEW YORK (GenomeWeb) – MGI, a subsidiary of BGI, has received the medical device registration certificate from the China Food and Drug Administration for its two next-generation sequencers, MGISEQ-2000 and MGISEQ-200. The certification enables healthcare organizations to use the instruments for clinical purposes.

According to the company, the MGISEQ-2000 instrument has two different flow cells that enable users to combine different operating modes and can generate 1,080 gigabases of sequencing data within 48 hours. MGISEQ-200 can produce 60 gigabases of data in less than 48 hours.

MGI launched the instruments last year.

The Scan

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce.

Biotech Co-Founder Arrested

A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News.

Return of the Tasmanian Tiger

The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction.

Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More

In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.